Skip to main content
. 2020 Mar 6;11(5):1339–1343. doi: 10.1111/1759-7714.13390

Figure 4.

Figure 4

(a) Rebiopsy after 30 times of pembrolizumab administration. (b) Pathologically, there was no malignant cell recurrence in the cryobiopsy sample. (c) The bronchial epithelium had completely regenerated. (d) Fibroblastic proliferation and infiltration of lymphocytes were observed in the submucosal space.